Page last updated: 2024-12-08

ra v

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

RA V: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	11979419
MeSH ID	M0128084

Synonyms (7)

Synonym
tpc-a
ra v
5-(n-methyl-l-tyrosine)bouvardin hydrate (4:5)
bouvardin, 5-(n-methyl-l-tyrosine)-, hydrate (4:5)
nsc 259969
TUBWTFZPLDUNIL-HJJYVODLSA-N
AKOS040734593

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	3 (16.67)	18.7374
1990's	3 (16.67)	18.2507
2000's	2 (11.11)	29.6817
2010's	9 (50.00)	24.3611
2020's	1 (5.56)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	1 (5.56%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	17 (94.44%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
tyrosine Tyrosine: A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.. tyrosine : An alpha-amino acid that is phenylalanine bearing a hydroxy substituent at position 4 on the phenyl ring.	2.07	1	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine	EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical
vancomycin Vancomycin: Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.. vancomycin : A complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile.	3.17	1	glycopeptide	antibacterial drug; antimicrobial agent; bacterial metabolite
nsc 259,968 bouvardin: cyclic hexapeptide from plant Bouvardia ternifolia	2.38	2
glycosides [no description available]	2.01	1
ra vii RA VII: structure given in first source	4.48	7
plitidepsin plitidepsin: a cyclodepsipeptide isolated from Aplidium albicans; has a pyruvoyl-proline residue instead of the lactyl-proline residue found in the linear peptide moiety of didemnin B. plitidepsin : A didemnin that is didemin B in which the hydroxy group of the 1-(2-hydroxypropanoyl)-L-prolinamide moiety has been oxidised to the corresponding ketone. It was originally isolated from the Mediterranean tunicate Aplidium albicans.	3.17	1	didemnin	anticoronaviral agent; antineoplastic agent; marine metabolite
cytochrome c-t Cytochromes c: Cytochromes of the c type that are found in eukaryotic MITOCHONDRIA. They serve as redox intermediates that accept electrons from MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX III and transfer them to MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV.	2.15	1
gramicidin a Gramicidin: A group of peptide antibiotics from BACILLUS brevis. Gramicidin C or S is a cyclic, ten-amino acid polypeptide and gramicidins A, B, D are linear. Gramicidin is one of the two principal components of TYROTHRICIN.	3.17	1
oligonucleotides [no description available]	2.21	1
daptomycin [no description available]	3.17	1
cyclosporine Cyclosporine: A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).	3.17	1
astin c astin C: from root of Aster tataricus; structure given in first source	3.17	1
ra xii RA XII: structure given in first source; isolated from Rubia cordifolia	2.01	1

Condition	Relationship Strength	Studies
Disease Exacerbation [description not available]	2.41	1
Cancer of Colon [description not available]	2.21	1
Colonic Neoplasms Tumors or cancer of the COLON.	2.21	1
Breast Cancer [description not available]	2.5	2
Invasiveness, Neoplasm [description not available]	2.11	1
Breast Neoplasms Tumors or cancer of the human BREAST.	2.5	2
Benign Neoplasms [description not available]	2.99	1
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	2.99	1
Carcinoma, Lewis Lung A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.	2.03	1
Angiogenesis, Pathologic [description not available]	2.03	1
Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.	1.96	1
Cancer of Mouth [description not available]	1.96	1
Cancer of Nasopharynx [description not available]	1.96	1
Experimental Mammary Neoplasms [description not available]	1.96	1
Mouth Neoplasms Tumors or cancer of the MOUTH.	1.96	1
Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX.	1.96	1
Leukemia L 1210 [description not available]	1.98	1

chemdatabank.com